368 related articles for article (PubMed ID: 17572198)
1. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.
Lambert EH; Bolte K; Masson P; Katz AE
Urology; 2007 Jun; 69(6):1117-20. PubMed ID: 17572198
[TBL] [Abstract][Full Text] [Related]
2. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation.
Ellis DS; Manny TB; Rewcastle JC
Urology; 2007 Feb; 69(2):306-10. PubMed ID: 17320669
[TBL] [Abstract][Full Text] [Related]
3. Cryosurgical ablation of the prostate: high risk patient outcomes.
Prepelica KL; Okeke Z; Murphy A; Katz AE
Cancer; 2005 Apr; 103(8):1625-30. PubMed ID: 15747374
[TBL] [Abstract][Full Text] [Related]
4. Rationale for a "male lumpectomy," a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up.
Onik G
Cardiovasc Intervent Radiol; 2008; 31(1):98-106. PubMed ID: 17593431
[TBL] [Abstract][Full Text] [Related]
5. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results.
Ellis DS; Manny TB; Rewcastle JC
Urology; 2007 Dec; 70(6 Suppl):9-15. PubMed ID: 18194712
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience.
Koppie TM; Shinohara K; Grossfeld GD; Presti JC; Carroll PR
J Urol; 1999 Aug; 162(2):427-32. PubMed ID: 10411051
[TBL] [Abstract][Full Text] [Related]
7. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.
Polascik TJ; Nosnik I; Mayes JM; Mouraviev V
Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220
[TBL] [Abstract][Full Text] [Related]
8. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
[TBL] [Abstract][Full Text] [Related]
9. Prostate cryoablation: prospective analysis comparing high- and low-risk prostate cancer outcomes.
El Hayek OR; Alfer W; Reggio E; Pompeo AC; Arap S; Lucon AM; Srougi M
Urol Int; 2008; 81(2):186-90. PubMed ID: 18758217
[TBL] [Abstract][Full Text] [Related]
10. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy.
Bales GT; Williams MJ; Sinner M; Thisted RA; Chodak GW
Urology; 1995 Nov; 46(5):676-80. PubMed ID: 7495120
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer.
Donnelly BJ; Saliken JC; Brasher PM; Ernst SD; Rewcastle JC; Lau H; Robinson J; Trpkov K
Cancer; 2010 Jan; 116(2):323-30. PubMed ID: 19937954
[TBL] [Abstract][Full Text] [Related]
12. "Male lumpectomy": focal therapy for prostate cancer using cryoablation.
Onik G; Vaughan D; Lotenfoe R; Dineen M; Brady J
Urology; 2007 Dec; 70(6 Suppl):16-21. PubMed ID: 18194706
[TBL] [Abstract][Full Text] [Related]
13. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience.
Ghafar MA; Johnson CW; De La Taille A; Benson MC; Bagiella E; Fatal M; Olsson CA; Katz AE
J Urol; 2001 Oct; 166(4):1333-7; discussion 1337-8. PubMed ID: 11547068
[TBL] [Abstract][Full Text] [Related]
14. Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.
Chung CS; Chen MH; Cullen J; McLeod D; Carroll P; D'Amico AV
Urology; 2008 Jan; 71(1):136-40. PubMed ID: 18242382
[TBL] [Abstract][Full Text] [Related]
15. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
16. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
[TBL] [Abstract][Full Text] [Related]
17. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients.
Ismail M; Ahmed S; Kastner C; Davies J
BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081
[TBL] [Abstract][Full Text] [Related]
18. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience.
Siddiqui SA; Mynderse LA; Zincke H; Hoffmann NE; Lobo JR; Wilson TM; Kawashima A; Davis BJ; Blute ML
Urology; 2007 Jul; 70(1):80-5. PubMed ID: 17656213
[TBL] [Abstract][Full Text] [Related]
19. Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?
Nielsen ME; Makarov DV; Humphreys E; Mangold L; Partin AW; Walsh PC
Urology; 2008 Aug; 72(2):389-93; discussion 394-5. PubMed ID: 18279937
[TBL] [Abstract][Full Text] [Related]
20. Primary cryoablation nadir prostate specific antigen and biochemical failure.
Levy DA; Pisters LL; Jones JS
J Urol; 2009 Sep; 182(3):931-7. PubMed ID: 19616226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
